Company intelligence / Profile preview

Shantha Biotechnics

Medchal, Telangana, Indiashanthabiotech.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

Shantha was India’s first biotech to develop an indigenously produced recombinant hepatitis B vaccine launched in 1997 at affordable prices. It developed multiple WHO-prequalified pediatric combination vaccines. The company faced challenges after WHO cancelled prequalification of its pentavalent vaccine but survived through support from parent Sanofi. It has expanded into oncology biosimilars and small molecules alongside its strong vaccine portfolio.

Therapeutic areas
OncologyInfectious Diseases
Modalities
Recombinant DNA vaccinesBiosimilars/biologics such as recombinant interferon alpha 2b and erythropoietinSmall molecule oncology drugs (e.g., epirubicin, gemcitabine)
Industry
Biotech
02

Drug pipeline

3 assets

Shan5

4

2 more assets in the full pipeline.

Request access →
03

Partnerships

Collaborations with international organizations UNICEF and PAHO for global vaccination supplypartnerships with US NIH, Bill & Melinda Gates Foundationacademic collaborations with Indian research institutes like CCMB.

Beyond the preview

Go deeper on Shantha Biotechnics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shantha Biotechnics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call